Kumar Neilinsider trades

In SEC Form 4 filings, Kumar Neil is listed as Chief Executive Officer of BridgeBio Pharma, Inc. (BBIO). In the last 90 days, Kumar Neil sold $690.8K of BridgeBio Pharma, Inc. (BBIO) on the open market and bought none. All 2 sales were reported under a 10b5-1 trading plan.

Companies and roles

Company	Role	Transactions	Last filed
BBIOBridgeBio Pharma, Inc.	Chief Executive Officer	2	Sep 21

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-21

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
BBIOBridgeBio Pharma, Inc.	Sep 17	Sep 21	S	8,721	$69.01	Sale −$601,868	496,965	Yes	Form 4
BBIOBridgeBio Pharma, Inc.	Sep 17	Sep 21	S	1,279	$69.57	Sale −$88,980	495,686	Yes	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.